Subsidiary Heidelberg Pharma contracts Celonic
Contract contains antibody cell line development and antibody production
28-Sep-2016 -
WILEX AG, announced that its subsidiary Heidelberg Pharma, has signed an agreement with Celonic AG, Basel, Switzerland, a specialist in the development and manufacturing of biologics (CDMO). This agreement includes cell line development and the production of non-GMP and GMP (Good Manufacturing ...
antibodies
antibody production
cell line development
+3